Skip to main content
. 2017 Mar 7;32(5):737–743. doi: 10.3346/jkms.2017.32.5.737

Table 1. OIs and seropositive rates for GBS (serotypes Ia, Ib, and III) in various IVIG products and in Korean infants.

Variables GMIs (95% CIs) Seropositive rate, No. (%)
Serotype Ia Serotype Ib Serotype III Serotype Ia Serotype Ib Serotype III
IVIG (No.)
 Korea-A (6) 778 (672–905) 525 (504–547) 1,614 (1,428–1,823) - - -
 Korea-B (10) 1,195 (820–1,742) 546 (528–565) 1,948 (1,569–2,420) - - -
 Korean products (16) 1,018 (786–1,319) 538 (524–553) 1,816 (1,567–2,103) - - -
 Total (19) 1,185 (900–1,560) 607 (531–693) 1,981 (1,690–2,322) - - -
Infants' sera, mon (No.)
 0–2 (22) 2.7 (2.0–3.7) 6.2 (3.2–11.8) 6.4 (3.1–13.5) 4 (18.2) 9 (40.9) 8 (36.4)
 3–5 (14) 2.3 (1.8–3.0) 3.3 (1.7–6.5) 3.8 (1.8–8.0) 1 (7.1) 2 (14.3) 3 (21.4)
 6–8 (34) 2.7 (2.0–3.6) 7.3 (3.5–15.3) 7.7 (3.8–15.7) 5 (14.7) 11 (32.4) 12 (35.3)
 9–11 (28) 3.5 (2.4–5.2) 14.7 (6.5–33.2) 22.0 (8.4–57.7) 8 (28.6) 16 (57.1) 15 (53.6)
 Total (98) 2.7 (2.3–3.2) 6.1 (4.2–8.9) 6.9 (4.6–10.5) 18 (18.4)* 38 (38.8) 38 (38.8)

OIs = opsonization indices, GBS = group B streptococcus, CIs = confidence intervals, IVIG = intravenous immunoglobulin, GMIs = geometric mean indices.

*Significant difference in the seropositive rates based on Cochran's Q test (P = 0.002).